Tight Closed-loop Systolic Arterial Pressure Control

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Cardiovascular Diseases
Interventions
DEVICE

Closed-loop vasopressor

The system will adjust the norepineprhine infusion rate based on a target SAP of 130 mmHg in 20 patients

Trial Locations (1)

1070

Erasme, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT04357301 - Tight Closed-loop Systolic Arterial Pressure Control | Biotech Hunter | Biotech Hunter